0001437749-18-003793.txt : 20180302 0001437749-18-003793.hdr.sgml : 20180302 20180302163128 ACCESSION NUMBER: 0001437749-18-003793 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180301 FILED AS OF DATE: 20180302 DATE AS OF CHANGE: 20180302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Klausner Mark R. CENTRAL INDEX KEY: 0001732629 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36200 FILM NUMBER: 18662479 MAIL ADDRESS: STREET 1: C/O OXFORD IMMUNOTEC GLOBAL STREET 2: 94C INNOVATION DRIVE, MILTON PARK CITY: ABINGDON, OXFORDSHIRE STATE: X0 ZIP: OX14 4RZ ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oxford Immunotec Global PLC CENTRAL INDEX KEY: 0001586049 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ BUSINESS PHONE: 44 01235 442780 MAIL ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ 4 1 rdgdoc.xml FORM 4 X0306 4 2018-03-01 0001586049 Oxford Immunotec Global PLC OXFD 0001732629 Klausner Mark R. C/O OXFORD IMMUNOTEC GLOBAL 94C INNOVATION DRIVE ABINGDON, OXFORDSHIRE X0 OX14 4RZ UNITED KINGDOM 1 SHARE OPTION (RIGHT TO BUY) 10.93 2018-03-01 4 A 0 3728 0 A 2028-03-01 ORDINARY SHARES 3728 3728 D SHARE OPTION (RIGHT TO BUY) 10.93 2018-03-01 4 A 0 14914 0 A 2028-03-01 ORDINARY SHARES 14914 14914 D This option will vest and become exercisable as to 100% of the underlying shares on the date of the first annual meeting of the issuer's shareholders held after the date of grant. This option will vest and become exercisable as to one-third of the shares on each date on which the first three annual meetings of the issuer's shareholders are held after the date of grant. /s/ Elizabeth M. Keiley, as Attorney-in-Fact for Mark Klausner 2018-03-02